Scientists are searching for the secret in Doug Whitney’s biology that has protected him from dementia, hoping it could lead to ways to treat or prevent Alzheimer’s for many other people.

Want to age well? Researchers in psychological and brain sciences are exploring what helps people live better and longer.

Experts say the answer is a puzzle.

Delaying HRT could do more harm than good, a new study shows.

As part of a monthly seminar hosted by the Harvey A. Friedman Center for Aging at The Brown School, Bethany Goff, MSW, LCSW, MA, EverTrue, presents on the Guiding an Improved Dementia Experience (GUIDE) Model. The GUIDE Model focuses on comprehensive, coordinated dementia care and aims to improve quality of life for people with dementia, reduce strain on their unpaid caregivers, and enable people with dementia to remain in their homes and communities. It will achieve these goals through Medicare payments for a comprehensive package of care coordination and care management, caregiver education and support, and respite services. It advances key goals of the National Plan to Address Alzheimer’s Disease, which was established through the bipartisan National Alzheimer’s Project Act (NAPA) and has, for over a decade, accelerated federal actions to optimize the quality of care for people with dementia and their caregivers while advancing research towards a cure. The GUIDE Model builds off of this extensive coordination within Health and Human Services and major input from various external stakeholders.

A combination of FDA-approved medication and lifestyle considerations can help people with Alzheimer's disease and their caregivers manage episodes of agitation.

Researchers at Washington University School of Medicine led by Alex Holehouse have developed a novel method of predicting how certain hard-to-study proteins will behave, with potential implications for research and treatment of many diseases.

Eric J. Lenze, MD, and his team at Washington University School of Medicine in St. Louis' Healthy Mind Lab are among 40 semifinalists in the XPRIZE Healthspan competition awarded $250,000 to study approaches to improve healthy aging.

The award-winning Mediterranean diet helps prevent dementia, especially in people at highest genetic risk, according to a new study.

After 25 years of research on this notable group, here’s what stands out.

Washington University in St. Louis School of Medicine researchers identify biomarkers of Alzheimer’s, Parkinson’s and frontotemporal dementia from blood plasma, suggesting new therapeutic avenues.

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new study.

Lifestyle interventions can slow cognitive decline in your 60s and 70s, according to a large randomized controlled trial. Here’s how.

As a caregiver of someone with Alzheimer’s, you know that agitation and aggressive behavior can happen from time to time.

Practical tips can help you manage mild cognitive changes and boost brain health. Small adjustments to your daily routine can help you stay mentally active and engaged.

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

Families and experts share their best advice for navigating and coping.

Our genomes are peppered with DNA segments called retrotransposons that can move from place to place. When unleashed, some can kill nerves and promote inflammation — a discovery that may inspire treatments for neurodegeneration.

A new study by Washington University in St. Louis School of Medicine researchers suggests that lemborexant and sleep aids that work the same way could help treat or prevent damage caused by harmful buildup of the protein tau in multiple neurodegenerative diseases, including Alzheimer’s.

Healthy eating might help protect your brain, experts say, but other factors play in as well.

A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ from the buildup of the tau protein – a key biomarker in the development of neurodegenerative diseases including Alzheimer's.